Cargando…

Authors’ Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis

Detalles Bibliográficos
Autores principales: Pope, Janet, Sawant, Ruta, Tundia, Namita, Du, Ella X., Qi, Cynthia Z., Song, Yan, Tang, Patrick, Betts, Keith A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107153/
https://www.ncbi.nlm.nih.gov/pubmed/33742364
http://dx.doi.org/10.1007/s12325-021-01642-9
_version_ 1783689899899092992
author Pope, Janet
Sawant, Ruta
Tundia, Namita
Du, Ella X.
Qi, Cynthia Z.
Song, Yan
Tang, Patrick
Betts, Keith A.
author_facet Pope, Janet
Sawant, Ruta
Tundia, Namita
Du, Ella X.
Qi, Cynthia Z.
Song, Yan
Tang, Patrick
Betts, Keith A.
author_sort Pope, Janet
collection PubMed
description
format Online
Article
Text
id pubmed-8107153
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-81071532021-05-24 Authors’ Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis Pope, Janet Sawant, Ruta Tundia, Namita Du, Ella X. Qi, Cynthia Z. Song, Yan Tang, Patrick Betts, Keith A. Adv Ther Letter Springer Healthcare 2021-03-20 2021 /pmc/articles/PMC8107153/ /pubmed/33742364 http://dx.doi.org/10.1007/s12325-021-01642-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Letter
Pope, Janet
Sawant, Ruta
Tundia, Namita
Du, Ella X.
Qi, Cynthia Z.
Song, Yan
Tang, Patrick
Betts, Keith A.
Authors’ Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis
title Authors’ Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis
title_full Authors’ Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis
title_fullStr Authors’ Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis
title_full_unstemmed Authors’ Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis
title_short Authors’ Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis
title_sort authors’ response to letter to the editor regarding comparative efficacy of jak inhibitors for moderate-to-severe rheumatoid arthritis: a network meta-analysis
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107153/
https://www.ncbi.nlm.nih.gov/pubmed/33742364
http://dx.doi.org/10.1007/s12325-021-01642-9
work_keys_str_mv AT popejanet authorsresponsetolettertotheeditorregardingcomparativeefficacyofjakinhibitorsformoderatetosevererheumatoidarthritisanetworkmetaanalysis
AT sawantruta authorsresponsetolettertotheeditorregardingcomparativeefficacyofjakinhibitorsformoderatetosevererheumatoidarthritisanetworkmetaanalysis
AT tundianamita authorsresponsetolettertotheeditorregardingcomparativeefficacyofjakinhibitorsformoderatetosevererheumatoidarthritisanetworkmetaanalysis
AT duellax authorsresponsetolettertotheeditorregardingcomparativeefficacyofjakinhibitorsformoderatetosevererheumatoidarthritisanetworkmetaanalysis
AT qicynthiaz authorsresponsetolettertotheeditorregardingcomparativeefficacyofjakinhibitorsformoderatetosevererheumatoidarthritisanetworkmetaanalysis
AT songyan authorsresponsetolettertotheeditorregardingcomparativeefficacyofjakinhibitorsformoderatetosevererheumatoidarthritisanetworkmetaanalysis
AT tangpatrick authorsresponsetolettertotheeditorregardingcomparativeefficacyofjakinhibitorsformoderatetosevererheumatoidarthritisanetworkmetaanalysis
AT bettskeitha authorsresponsetolettertotheeditorregardingcomparativeefficacyofjakinhibitorsformoderatetosevererheumatoidarthritisanetworkmetaanalysis